Links
Organizations
Conferences
Info & Opinion
October 10, 2008
Three Ticking Clocks
Bayer Halts Trasylol Sales
With journal editors in charge of drug safety, the political system has failed the industry and the public.
- Home
- Tag
- jama
In another significant win for medical journal editors in their new role as regulators, Bayer suspended sales of anti-clotting drug Trasylol (aprotinin), which had been implicated in kidney failure, cardiovascular problems and mortality risk. The drug had approximately $135 million…
No articles available
